A Rapid in Vitro Assay for Quantitating the Invasive Potential of Tumor Cells

Cancer Research

Volumn 47, Issue 12, 1987, Pages 3239-3245

  McEwan, R N ^e   Kleinman, H K ^b   Martin, G R ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ASSAY; BASEMENT MEMBRANE; CANCER INVASION; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE GENITAL SYSTEM; METASTASIS; METHODOLOGY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; TUMOR CELL;

ANIMAL; BASEMENT MEMBRANE; FIBROBLASTS; HUMAN; IN VITRO; MALE; MELANOMA; MICE; MICE, INBRED C3H; MICROSCOPY, PHASE-CONTRAST; NEOPLASM INVASIVENESS; PHENOTYPE; PROSTATIC HYPERPLASIA;

EID: 0023187867     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Vracko, R. Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. Am. J. Pathol., 77:314-338, 1974.
2. Timpl, R., Rohde, H., Robey, P. G., Rennard, S. I., Foidart, J. M., and Martin, G. R. Laminin—a glycoprotein from basement membrane. J. Biol. Chem., 254:9933-9937, 1979.
3. Laurie, G. W., Leblond, C. P., and Martin, G. R. Localization of type IV collagen, laminin, heparan sulfate proteoglycan and fibronectin to the basal lamina of basement membranes. J. Cell Biol., 95: 340–344, 1982.
4. Timpl, R., Fujiwara, S., Dziadek, M., Aumailley, M., Weber, S., and Engel
5. R. Reich, unpublished observations.
6. L. Auckerman, A. Albini, and I. J. Fidler, manuscript in preparation. J. Laminin, proteoglycan, nidogen, and collagen IV: structural models and molecular interactions. In: R. Porter and J. Whelan (eds.), Basement Membranes and Movement, pp. 25-74. London: Pitman, 1984.
7. Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., and Martin, G. R. Basement membrane complexes with biological activity. Biochemistry, 25:312-318, 1986
8. Liotta, L. A. Tumor invasion and metastases: role of the basement membrane. Am. J. Pathol., 117:339-348, 1984.
9. Nicolson, G. L. Cancer metastasis: organ colonization and the cell surface properties of malignant cells. Biochim. Biophys. Acta, 695:113-176, 1982.
10. Terranova, V. P., Liotta, L. A., Russo, R. G., and Martin, G. R. Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res., 42:2265-2269, 1982.
11. Levine, E., Birk, D. E., and Raslca, K. Attachment and degration of collagen substrate by adenovirus-transformed cells of varying tumorigenicity. Collagen Relat. Res., 4:49-62, 1984.
12. Rao, C. N., Barsky, S. H., Terranova, V. P., and Liotta, L. A. Isolation of a tumor cell laminin receptor. Biochem. Biophys. Res. Commun., 111: 804-808, 1983.
13. Malinoff, H. L., and Wicha, M. S. Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells. J. Cell Biol., 96: 1475–1479, 1983.
14. Lesot, H., Kuhn, K., and von der Mark, K. Isolation of a laminin binding protein from muscle cell membrane. EMBO J., 2:861-865, 1985.
15. Jones, P. A., and DeClerck, Y. A. Destruction of extracellular matrices containing glycoproteins, elastin and collagen by metastatic human tumor cells. Cancer Res., 40:3222-3227, 1980.
16. Kramer, R. H., and Vogel, K. G. Selective degradation of basement membrane macromolecules by metastatic melanoma cells. J. Natl. Cancer Inst., 72: 8889-8899, 1984.
17. Turpeenniemi-Hujanen, T., Thorgeirsson, U. P., Rao, C. N., and Liotta, L. A. Laminin increases the release of type IV collagenase from malignant cells. J. Biol. Chem., 261:1883-1889, 1986.
18. Volk, T., Geiger, B., and Raz, A. Motility and adhesive properties of high-and low-metastatic neoplastic cells. Cancer Res., 44:811-824, 1984.
19. McCarthy, J. B., Basara, M. L., Palm, S. L., Sas, D. F., and Furcht, F. T. The role of cell adhesion proteins, laminin, and fibronectin in the movement of malignant and metastatic cells. Cancer Metastasis Rev., 4:125-152, 1985.
20. Mensing, H., Albini, A., Krieg, T., Pontz, B. F., and Mueller, P. K. Enhanced chemotaxis of tumor-derived and virus-transformed cells to fibronectin and fibroblast conditioned medium. Int. J. Cancer, 33:43-48, 1984.
21. Hujanen, E. S., and Terranova, V. P. Migration of tumor cells to organ-derived chemoattractants. Cancer Res., 45:3517-3521, 1985.
22. Terranova, V. P., Hujanen, E. S., and Martin, G. R. Basement membrane and the invasive activity of metastatic tumor cells. J. Natl. Cancer Inst., 77: 311-316, 1986.
23. Hart, I. R., and Fidler, I. J. An in vitro quantitative assay for tumor cell invasion. Cancer Res., 38:3218-3224, 1978
24. Liotta, L. A., Lee, W. C., and Moralris, D. J. New method for preparing large surfaces of intact basement membrane for tumor invasion studies. Cancer Lett, 11:141-147, 1980.
25. Starkey, J. R., Hosick, H. L., Stanford, D. R., and Liggitt, H. D. Interaction of metastatic tumor cells with bovine lens. Cancer Res., 44: 1585–1594, 1984.
26. Marcel, M. M., DeBruyre, G. K., Vandesande, F., and Dragonetti, C. Immunohistochemical study of embryonic chick heart invaded by malignant cells in three-dimensional culture. Invasion Metastasis, 1:195-204, 1981.
27. Terranova, V. P., Hujanen, E. S., Loeb, D. M., Martin, G. R., Thornburg, L., and Glushko, V. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proc. Natl. Acad. Sci. USA, 83:465-469, 1986.
28. Kramer, R. H., Bensch, K. K., and Wong, J. Invasion of reconstituted basement membrane matrix by metastatic tumor cells. Cancer Res., 46: 1980-1989, 1986
29. Mensing, H., Pontz, B. F., Muller, P. K., and Gauss-Muller, V. A study on fibroblast chemotaxis using fibronectin and conditioned medium as chemoattractants. Eur. J. Cell Biol., 29:268-273, 1983.
30. Fidler, I. J. Selection of successive tumor lines for metastasis. Nature New Biol., 242:148-149, 1973.
31. Fidler, I. J., Gruys, E., Cifone, M. A., Barnes, Z., and Bucana, C. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J. Natl. Cancer Inst., 67:947-956, 1981.
32. Talmadge, J. E., and Fidler, I. J. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J. Natl. Cancer Inst, 69:975-980, 1982.
33. Jacobs, G. P., Jones, E. M., and Bailie, J. P. Characteristics of a human diploid cell designated MRC-5. Nature (Lond.), 227:168-170, 1970.
34. Reznikoff, C. A., Brankow, D. W., and Heidelberger, C. Establishment of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res., 33:3231-3238, 1973.
35. Sykes, J. A., Whitescarver, J., Jernstron, P., Nolan, J. F., and Byatt, P. Some properties of a new epithelial cell line of human origin. J. Natl. Cancer Inst., 45:107-122, 1970.
36. Fogh, J., and Trempe, G. In: J. Fogh (ed.), Human Tumor Cells in Vitro, pp. 115–159. New York: Plenum Press, 1975.
37. Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., and Parks, W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J. Natl. Cancer Inst., 51:1417-1423, 1973.
38. Leibovitz, A., Stinson, J. C., McCombs, W. B., McCoy, C. E., Mazur, K. C., and Mabry, N. Classification of human colorectal adenocarcinoma cell lines. Cancer Res., 36:4562-4569, 1976.
39. Zeuthen, J., Norgaard, J. O. R., Avner, P., Fellous, M., Wartiovaara, J., Vaheri, A., Rosen, A., and Giovannella, B. C. Characterization of a human ovarian teratocarcinoma-derived line. Int. J. Cancer, 25: 19-32, 1980.
40. Rasheed, S., Nelson-Rees, W. A., Toth, E. M., Arnstein, P., and Gardner, M. B. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer (Phila.), 33:1027-1033, 1974.
41. Bubenik, J., Baresova, M., Viklicky, V., Jakoubkova, J., Sainerova, H., and Donner, J. Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int. J. Cancer, 11:765-773, 1973.
42. Reddy, E. P., Reynolds, R. K., Santos, E., and Barbacid, M. A point mutation is responsible for the acquisition of transforming properties by the T24 bladder carcinoma oncogene. Nature (Lond.) 300:149-152, 1982.
43. Yuasa, Y., Snivastava, S. K., Dunn, C. Y., Rhin, J. S., Reddy, E. P., and Aaronson, S. A. Acquisition of transforming properties by ailternative point mutations within c-bas/ras human proto-oncogene. Nature (Lond.), 303: 775–779, 1983.
44. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., and Paulsen, D. F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer, 27:274-281, 1978.
45. Kaighn, M. E., Shankar, N., Ohnuki, Y., Lechner, J. F., and Jones, L. W. Establishment and characterization of a human prostate carcinoma cell line (PC-3). Invest. Urol., 17: 16-23, 1979.
46. Chaproniere, D. M., and McKeehan, W. L. Serial culture of single adult human prostatic epithelial cells in serum-free medium containing low calcium and a new growth factor from bovine brain. Cancer Res. 46:819-824, 1986.
47. Lowry, O.H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265–275, 1951.
48. Albini, A., Muller, P. K., and Parodi, S. A method to select cell populations with enhanced chemotactic activity. Biosci. Rep., 4:311-318, 1984.
49. Kozlowski, J. M., Fidler, I. J., Campbell, D., Xu, Z-L., Kaighn, M. E., and Hart, I. R. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res., 44:3522-3529, 1984.
50. Fujita, J., Srivastava, S. V., Kraus, M. H., Rhim, J. S., Tronick, S. R., and Aaronson, S. A. Frequency of molecular alterations affecting ras protooncogenes in urinary tract tumors. Proc. Natl. Acad. Sci. USA, 82:3849-3853, 1985.
51. Yuasa, Y., Gol, R. A., Chang, A., Chiu, I. M., Reddy, P., Tronick, S., and Aaronson, S. A. Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells. Proc. Natl. Acad. Sci. USA, 81: 3670–3674, 1984.
52. Thorgeirsson, U. P., Turpeenniemi-Hujanen, T., Williams, J. E., Westin, E. J., Heilman, C. A., Talmadge, J. E., and Liotta, L. A. NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogene express the metastatic phenotype in nude mice. Molec. Cell. Biol., 5: 259-262, 1985.
53. Greig, R. G., Koestler, T. P., Trainer, L., Corwin, S. P., Milen, U., Kline, T., Sweet, R., Yokayama, S., and Poste, G. Tumorgenic and metastatic properties of “normal” and ras-transfected NIH/3T3 cell. Proc. Natl. Acad. Sci. USA, 82:3698-3701, 1985.
54. Crissman, J. D., Hatfield, J., Schaldenband, M., Sloane, B. F., and Honn, K. V. Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study. Lab. Invest., 53:470-479, 1985.
55. Liotta, L. A., Mandler, R., Murano, G., Katz, D. A., Gordon, R. K., Chiang, P. K., and Schiffmann, E. Tumor cell autocrine motility factor. Proc. Natl. Acad. Sci. USA, 83:3302-3306, 1986.
56. Albini, A., Graf, J., Kitten, G. T., Kleinman, H. K., Martin, G. R., Veillette, A., and Lippman, M. E. 17-0-Estradiol regulates and v-ras transfection constitutively enhances MCF-7 breast cancer cells interactions with basement membrane. Proc. Natl. Acad. Sci. USA, 83:8182-8186, 1986.
57. Fidler, I. J., and Kripke, M. L. Metastasis results from pre-existing variant cells within a malignant tumor. Science (Wash. DC), 197:893-895, 1977.
58. Fidler, I. J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res., 38:2651-2660, 1978.